YungShin Global Holding Co (TPE:3705) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:3705 YungShin Global Holding Co Ltd TPE:3705
89 GF Score
Price NT$53.80
GF Value NT$55.34
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is YungShin Global Holding Co FFO per Share?

FFO per Share only applies to REITs.

TPE:3705
89GF Score
YungShin Global Holding Co Ltd TPE:3705
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is YungShin Global Holding Co (TPE:3705) Overvalued in 2026?

Based on GuruFocus' analysis, YungShin Global Holding Co stock appears to be undervalued. The current stock price of NT$53.80 is trading 2.8% below its estimated GF Value™ of NT$55.34. GuruFocus considers YungShin Global Holding Co to be Fairly Valued.

Key valuation signals for TPE:3705:

  • FFO per Share:
  • GF Value™: NT$55.34 vs. price of NT$53.80 (2.8% below fair value)
  • GF Score™: 89/100 with 4 warning signs

No single metric tells the full story. See the TPE:3705 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


YungShin Global Holding Co Business Description

Address No. 315, Cheng Gong Road, Dajia District, Taichung, TWN
YungShin Global Holding Co Ltd invests, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics. The company derives revenue from the sale of Human drugs, Health food, Animal drugs, and Others. The company generates the majority of its revenue from Human drugs. Geographically, the company generates the revenue from Taiwan, the USA, Japan, and China, out of which the majority of its revenue is generated from Taiwan.
89GF Score

Get the complete analysis for TPE:3705

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$53.80
Price
NT$55.34
GF Value